companydata.dkcompanydata.dk

Renovaro Biosciences Denmark ApS: Financial statements 2018

CVR: 26027322

Source: annual report 2018, Danish Business Authority

01/07/2017 – 30/06/2018

Renovaro Biosciences Denmark ApS (CVR 26027322) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK -4,470,967 and a net result of DKK -7,012,131. Equity in the 2018 report amounted to DKK -55,793,173.

Gross Profit
DKK -4,470,967
Profit/Loss
DKK -7,012,131
Equity
DKK -55,793,173
Total Assets
DKK 3,073,582

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2018--4.5M-7M-55.8M-
2016--5M-10.7M-52M2
2015--17.4M-20.4M-41.3M-
2014--8.5M-11.5M-21M-
2013--5.6M-10.6M-9.5M-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2018

Henrik Grønfeldt-Sørensen joins Renovaro Biosciences Denmark ApS as adm. dir.Nov 15, 2018

As of November 15, 2018, Henrik Grønfeldt-Sørensen is registered as adm. dir. of Renovaro Biosciences Denmark ApS.

Eric Jean Marie Leire steps down as adm. dir. of Renovaro Biosciences Denmark ApSNov 15, 2018

As of November 15, 2018, Eric Jean Marie Leire has stepped down as adm. dir. of Renovaro Biosciences Denmark ApS.

DanDrit Biotech ApS changes name to Enochian BioSciences Denmark ApSNov 15, 2018

On November 15, 2018, the company changed its name from DanDrit Biotech ApS to Enochian BioSciences Denmark ApS.

Henrik Grønfeldt-Sørensen leaves the board of Renovaro Biosciences Denmark ApSApr 1, 2018

As of April 1, 2018, Henrik Grønfeldt-Sørensen has left the board of directors of Renovaro Biosciences Denmark ApS.

Torben Bjørn Christensen leaves the board of Renovaro Biosciences Denmark ApSApr 1, 2018

As of April 1, 2018, Torben Bjørn Christensen has left the board of directors of Renovaro Biosciences Denmark ApS.

Eric Jean Marie Leire leaves the board of Renovaro Biosciences Denmark ApSApr 1, 2018

As of April 1, 2018, Eric Jean Marie Leire has left the board of directors of Renovaro Biosciences Denmark ApS.

DANDRIT BIOTECH A/S changes name to DanDrit Biotech ApSApr 1, 2018

On April 1, 2018, the company changed its name from DANDRIT BIOTECH A/S to DanDrit Biotech ApS.

About Renovaro Biosciences Denmark ApS

Renovaro Biosciences Denmark ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2001. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Enochian BioSciences Denmark ApS and DanDrit Biotech ApS. The management consists of David Hershel Weinstein. The company is owned by Lunai Bioworks Inc.. The company has 1 employee (2017). In 2026, the company reported a gross profit of DKK -4,478 and a net result of DKK -1,178,038 compared with DKK -4,629,959 the year before. Equity in the 2026 report amounted to DKK -91,933,986.

Source: annual report 2026, Danish Business Authority